A clinical trial for ichthyosis: Testing the safety and effectiveness of a topical cream for adults and adolescents living with ichthyosis.

The Reflect Study is testing the safety and effectiveness of a topical cream for adults and adolescents living with Lamellar Ichthyosis (LI). This investigational cream is applied to the surface of the skin in an effort to reduce LI symptoms such as dry and cracked skin. The Reflect

Study aims to help improve symptoms of LI for current and future generations.

Those Who Qualify For Study Participation Can Expect The Following:

Study Duration: 12 weeks, with the option to continue for another 12 weeks (up to 24 weeks)

Treatment Received: All study participants will randomly receive either the study medication with the active ingredient or placebo for the first 12 weeks (2/3 likelihood of receiving study medication with active ingredient). Those study participants who complete the first 12 weeks of the study and wish to continue for another 12 weeks will receive study medication with the active ingredient (no one will receive placebo).

Treatment Frequency: Twice weekly.

You May Qualify for the Reflect Study If You:

  • Are 12 years of age or older
  • Have been diagnosed with lamellar ichthyosis
  • Have moderate to severe lamellar ichthyosis

See If You Qualify:

Additional study details, frequently asked questions, and contact information are available on the study website: IchthyosisStudy.com

STUDY LOCATIONS

United States

YALE UNIVERSITY
Principal Investigator: KEITH CHOATE
Study Coordinator: MAHIN DAWOOD
Address: New Haven, CT
Contact: mahin.dawood@yale.edu; 203.789.1249

CHILDREN'S HOSPITAL OF PHILADELPHIA
Principal Investigator: LESLIE CASTELO-SOCCIO
Study Coordinator: LISA CATANOSO
Address: Philadelphia, PA
Contact: catanosol@email.chop.edu; 215.590.2169

DAWES FRETZIN CLINICAL RESEARCH GROUP, LLC
Principal Investigator: KENNETH DAWES
Study Coordinator: SARAH L. RAGAN
Address: Indianapolis, IN
Contact: sragan@ecommunity.com; 317.516.5030

TCR MEDICAL CORPORATION
Principal Investigator: NEAL BHATIA
Study Coordinator: NICKY YAGUBOVA
Address: San Diego, CA
Contact: nyagubova@therapeuticsresearch.com; 858.571.6800

DERMASSOCIATES, PC
Principal Investigator: BEN LOCKSHIN
Study Coordinator: THOMAS BLONDO
Address: Rockville, MD
Contact: tblondo@dermassociates.com; 301.355.3183

MEDICAL UNIVERSITY OF SOUTH CAROLINA
Principal Investigator: LARA WINE LEE
Study Coordinator: CHARNELE HANDY
Address: Charleston, SC
Contact: handyc@musc.edu; 843.792.3021

TEXAS DERMATOLOGY AND LASER SPECIALISTS
Principal Investigator: JOHN BROWNING
Address: San Antonio, TX
Contact: drbrowning@texasdls.com; 210.852.2779

CHILDREN'S HOSPITAL COLORADO
Principal Investigator: ANNA BRUCKNER
Study Coordinator: KATHLEEN PEOPLES
Address: Aurora, CO
Contact: kathleen.peoples@childrenscolorado.org; 720.777.0955

MASSACHUSETTS GENERAL HOSPITAL - CLINICAL UNIT FOR RESEARCH TRIALS IN SKIN (CURTIS)
Principal Investigator: EVELYN LILLY
Study Coordinator: ELVIDA ARIAS
Address: Boston, MA
Contact: eyarias@mgh.harvard.edu; 617.726.5066

NORTHSHORE UNIVERSITY HEALTHSYSTEM
Principal Investigator: STEPHANIE MEHLIS
Study Coordinator: JUDY SPOLARICH-KROLL
Address: Skokie, IL
Contact: jspolarich-kroll@northshore.org; 847.663.8530

INTERNATIONAL

Canada

THE HOSPITAL FOR SICK CHILDREN
Principal Investigator: ELENA POPE
Study Coordinator: HANNA FADZEYEVA
Address: Toronto, M5G 1X8
Contact: hanna.fadzeyeva@sickkids.ca

Australia

ROYAL CHILDREN'S HOSPITAL
Principal Investigator: JOHN SU
Study Coordinator: JEMIMAH MATEER
Address: Parkville, 3052
Contact: jemimah.mateer@mcri.edu.au

PREMIER SPECIALISTS PTY LTD.
Principal Investigator: DEDEE MURRELL
Study Coordinator: HELEN DICKENSON-PANAS
Address: Sydney, 2217
Contact: d.murrell@unsw.edu.au; premierspecialiststrials@gmail.com

VERACITY CLINICAL RESEARCH
Principal Investigator: LYNDA SPELMAN
Study Coordinator: KURT DAVIDSON
Address: Brisbane, 4102
Contact: kdavidson@veracityclinicalresearch.com.au

EASTERN HEALTH MONASH UNIVERSITY
Principal Investigator: JOHN SU
Study Coordinator: BELINDA DRESSER
Address: Box Hill, 3111
Contact: belinda.dresser@monash.edu

France

CHU DE TOULOUSE - HOPITAL LARREY
Principal Investigator: JULIETTE MAZEREEUW-HAUTIER
Study Coordinator: HÉLÈNE TEXIER
Address: Toulouse, 31059
Contact: texier.h@chu-toulouse.fr

DERMATOLOGIE PÉDIATRIQUE / PÉDIATRIE GÉNÉRALE
Principal Investigator: CHRISTINE BODEMER
Study Coordinator: MIRANDOLIE FRIDA
Address: Paris, 75015
Contact: mirandolie.frida@institutimagine.org

CHU CHARLES NICOLLE
Principal Investigator: ANNE BENEDICTE DUVAL MODESTE
Study Coordinator: ORLANE DEBOVES
Address: Rouen, 76031
Contact: orlane.deboves@chu-rouen.fr

Spain

HOSPITAL CLÍNIC DE BARCELONA
Principal Investigator: SUSANA PUIG
Study Coordinator: PABLO IGLESIAS
Address: Barcelona, 08036
Contact: pabloiglesiasgarcia@msn.com

HOSPITAL NIÑO JESÚS
Principal Investigator: ANGELA HERNANDEZ
Study Coordinator: NURIA VENTOSINO
Address: Madrid, 28009
Contact: nuria.ventosino@salud.madrid.org

CLÍNICA UNIVERSIDAD DE NAVARRA
Principal Investigator: PEDRO REDONDO
Study Coordinator: IRENE BARRIENTOS
Address: Pamplona (Navarra), 31008
Contact: ibarrientos@unav.es

CLÍNICA UNIVERSIDAD DE NAVARRA (MADRID)
Principal Investigator: PEDRO REDONDO
Study Coordinator: MARILUZ MONTESINOS
Address: Madrid, 28027
Contact: mmontesinos@unav.es

Germany

UNIVERSITÄTSKLINKUM FRANKFURT
Principal Investigator: ANDREAS PINTER
Study Coordinator: KARINA TAMM
Address: Frankfurt, 60590
Contact: karina.tamm@kgu.de

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Principal Investigator: URIKE BLUME-PEYTAVI
Study Coordinator: ANNETTE ANDRUCK
Address: Berlin, 10117
Contact: annette.andruck@charite.de

LUDWIG-MAXIMILIANS UNIVERSITY
Principal Investigator: KATHRIN GIEHL
Study Coordinator: JULIA DILLARD
Address: Munich, 80337
Contact: julia.dillard@med.uni-muenchen.de

KATH. KINDERKRANKENHAUS WILHELMSTIFT
Principal Investigator: PETER HOEGER
Study Coordinator: ANDREA BRITSCH
Address: Hamburg, 22149
Contact: a.britsch@kkh-wilhelmstift.de

UNIVERSITATSMEDIZIN ROSTOCK
Principal Investigator: SUSEN RODE
Study Coordinator: GESINE BANDOW
Address: Rostock, 18057
Contact: gesine.bandow@med.uni-rostock.de

 

UK

ROYAL LONDON HOSPITAL BARTS HEALTH NHS TRUST
Principal Investigator: EDEL O'TOOLE
Study Coordinator: PAUL FOSTER COFIE
Address: London, E11BB
Contact: paulfoster.cofie@nhs.net

Israel

TEL AVIV SOURASKY MC
Principal Investigator: LIAT SAMUELOV
Study Coordinator: ZVI ISMAKIV
Address: Tel Aviv, 6423906
Contact: zviis@tlvmc.gov.il

Ukraine

MEDICAL CENTER OF PRIVATE ENTERPRISE “DZERKALO”
Principal Investigator: TETYANA SVYATENKO
Study Coordinator: OLHA STATKEVYCH
Address: Dnipro, 49000
Contact: statkevycholha@ukr.net

TDC PE "ASCLEPIUS"
Principal Investigator: YURIY ANDRASHKO
Study Coordinator: ROMAN YAREMKEVYCH
Address: Uzhhorod, 88000
Contact: r.yaremkevych@gmail.com

DNIPROPETROVSK STATE HOSPITAL OF DERMATOVENEROLOGY
Principal Investigator: ANATOLY DYUDYUN
Study Coordinator: NATALIIA POLION
Address: Dnipro, 49074
Contact: nnpolion@ua.fm

MEDICAL CENTER "FAMILY MEDICINE CLINIC"
Principal Investigator: NATALIIA KUZNETSOVA
Address: Dnipro, 49600
Contact: trials.ksm@gmail.com

MILITARY HOSPITAL (MILITARY UNIT A3309) OF MILITARY-MEDICAL CLINICAL CENTRE OF SOUTHERN REGION
Principal Investigator: NATALIYA REZNICHENKO
Address: Zaporizhzhya, 69063
Contact: n.reznichenkog@gmail.com

Return to Clinical Trial Page

Share This Page:

Search